Trial intelligence / Profile preview

ZO-Y49 Phase III clinical trial

jRCT2080220729Phase 3

Sponsor
Zeria Pharmaceutical Co., Ltd.
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of ethinylestradiol + norethisterone, sponsored by Zeria Pharmaceutical Co., Ltd.

02

Drugs

ethinylestradiol + norethisterone

Beyond the preview

Go deeper on jRCT2080220729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call